Kubo et al (1999) The p16 status of tumor cell lines identifies small molecule inhibitors specific for cyclin-dependent kinase 4. Clin.Cancer Res. 5 4279. McInnes et al (2004) Structural determinants of CDK4 inhibition and design of selective ATP competit
の阻害剤である:
APC13, Cdk4, cyclin D1, p21, PITSLRE A, TTC14, ZDHHC24.
身体の状態 :
Solid
溶解度 :
Soluble in DMSO (25 mg/ml), and ethanol (2.5 mg/ml).